Dolutegravir Impact on Residual Replication
Condition(s):HIVLast Updated:November 20, 2017Completed
Hide Studies Not Open or Pending
Condition(s):HIVLast Updated:November 20, 2017Completed
Condition(s):HIV-1-infectionLast Updated:July 28, 2021Recruiting
Condition(s):HIV Infection; HAART-treated; Virologically ControlledLast Updated:August 28, 2015Withdrawn
Condition(s):Pulmonary Tuberculoses; Other Specified Pulmonary TuberculosisLast Updated:February 24, 2022Active, not recruiting
Condition(s):Infection, Human Immunodeficiency VirusLast Updated:January 16, 2018Completed
Condition(s):HIV InfectionLast Updated:August 18, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.